Alzheimer's Club

A forum for non-censored ideas, news, research and technology on Alzheimer's disease


			_


							_

Alzheimer's cure: World General Media News Headlines

Alzheimer's treatment: World General Media News Headlines

Alzheimer theories: World General Media News Headlines

Alzheimer science professional news: Alzforum News & Views

February 05, 2007

Physicians do not always practice what drug watchdog preaches

The UK government's drug watchdog NICE has received a lot of publicity recently after publishing guidelines restricting the prescription of certain cognitive enhancers for Alzheimer's disease for reasons of cost. However, a recent survey of 181 neurologists by Datamonitor indicates that the NICE cost-benefit methodology may not reflect how the drug is actually used in the clinical setting.

'Content Cognitive enhancers do not treat the cause of Alzheimer's, rather they seek to prevent the cognitive decline associated with it, and fall into two categories: acetycholinesterase inhibitors (AChEIs) including Aricept (donepezil), Exelon (rivastigmine) and Razadyne (galantamine), or the NMDA antagonist memantine, which is branded as Namenda and Ebixa in the US and Europe respectively.

Source: PBR Staff Writer. Alzheimer's disease: physicians do not always practice what NICE preaches (5 Feb 2007) [FullText]

Labels: Alzheimer's watchdog

0 Comments:

Latest PubMed 20 review articles on Alzheimer’s

Latest PubMed 20 research articles on Alzheimer’s amyloid

Latest PubMed 50 research titles on Alzheimer’s

AlzClub Lay and Science News content is under automatic continuous update. Please check back often or subscribe to news of interest using RSS feed buttons below. Also, please email to us your news terms suggestions
A semi-fiction mystery novel "The Alzheimer Code" is under preparation. In this book the death of the President of the United States of America is followed by his preventive anti-amyloid vaccination against Alzheimer's disease. At the same time and for the same reason, in his agony of death Editor-in-Chief of London-based Nature science journal recalls he in fact witnessed the corruption of Alzheimer's pseudo-science, brought to the community by a keen student. This is a story of a corrupted Harvard University professor, a research center co-director and a godfather of the international network of science criminals. Be the first to know when Alzheimer Code is published, by subscribing to an AlzClub.org news alerts . Otherwise automate your Alzheimer’s information portfolio with a number of options presented at this page.
Subscribe to AlzClub Mailing List, and freely share your information directly with your peers by e-mail. Click here to prepare email message requesting AlzClub Mailing List subscription
Would you like to author articles at Alzheimer's Club? Then send us your masterpiece, so we can screen it and publish at Alzclub.org. Please note that comments (on articles published previously) can be posted directly and anonymously (but why you would stay not known to the public?)
Do you know that as of May 3, 2005 NIH asks NIH-funded scientists to deposit their articles (published earlier in scientific journals) in PubMedCentral (PMC)? PMC is accessible to all for free and is one form of the academic world movement towards Public Open Access to scholar literature, free from commercial publishers' cabal. New to Open Access? Then you miss important science publishing development, because an NIH provision became a US law at the end of 2007. Read lay language article on Open Access authored by AlzClub founder. NIH-funded authors: visit the NIH Manuscript Submission system for more information.